Usher syndrome: genes and variants
Explore variant evidence for Usher syndrome across 4 analyzed proteins (MYO7A, USH2A, PCDH15, USH1C). Linked ClinVar records include 128 pathogenic or likely pathogenic variants, 543 variants of uncertain significance and 113 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Usher syndrome
MYO7A: Unconventional myosin-VIIa
Its actin-based motor supports stereocilia organization in inner-ear hair cells and transport processes in retinal cells. Biallelic pathogenic variants cause Usher syndrome type 1B, while other alleles can cause nonsyndromic hearing loss.
80 ClinVar pathogenic / likely pathogenic and 179 uncertain variants in MYO7A have source records linked to Usher syndrome. Association strength is not clinical gene validity.
USH2A: Usherin
It helps organize extracellular and membrane structures required for cochlear hair-cell and photoreceptor function. Biallelic pathogenic variants cause Usher syndrome type 2A or nonsyndromic retinitis pigmentosa and can also produce isolated hearing loss.
40 ClinVar pathogenic / likely pathogenic and 223 uncertain variants in USH2A have source records linked to Usher syndrome. Association strength is not clinical gene validity.
PCDH15: Protocadherin-15
It forms part of the tip-link complex that converts mechanical deflection of inner-ear hair bundles into electrical signals and also supports photoreceptor structure. Biallelic pathogenic variants cause Usher syndrome type 1F or nonsyndromic hearing loss.
4 ClinVar pathogenic / likely pathogenic and 198 uncertain variants in PCDH15 have source records linked to Usher syndrome. Association strength is not clinical gene validity.
USH1C: Harmonin
It organizes protein complexes in inner-ear hair-cell stereocilia and photoreceptor structures. Biallelic pathogenic variants cause Usher syndrome type 1C with congenital severe hearing loss and progressive retinitis pigmentosa, or in some alleles isolated deafness.
4 ClinVar pathogenic / likely pathogenic and 53 uncertain variants in USH1C have source records linked to Usher syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ATP6V1B1, BBS1, CRX, PRPH2 and VSIR.
ClinVar pathogenic and likely pathogenic variants linked to Usher syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MYO7A R668C | 668 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A R1873Q | 1873 | MyTH4 2 | Pathogenic / likely pathogenic (★★★) |
| MYO7A L326Q | 326 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A Y403C | 403 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A H133N | 133 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A I134N | 134 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A S211G | 211 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A R1168Q | 1168 | MyTH4 1 | Pathogenic / likely pathogenic (★★★) |
| MYO7A L1935P | 1935 | FERM 2 | Pathogenic / likely pathogenic (★★★) |
| MYO7A N1182K | 1182 | MyTH4 1 | Pathogenic / likely pathogenic (★★★) |
| MYO7A V1372G | 1372 | FERM 1 | Pathogenic / likely pathogenic (★★★) |
| MYO7A G2187D | 2187 | FERM 2 | Pathogenic / likely pathogenic (★★★) |
| MYO7A K2021R | 2021 | FERM 2 | Pathogenic / likely pathogenic (★★★) |
| MYO7A T2109I | 2109 | FERM 2 | Pathogenic / likely pathogenic (★★★) |
| MYO7A E968D | 968 | Pathogenic / likely pathogenic (★★★) | |
| MYO7A A397T | 397 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A E450V | 450 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R668H | 668 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A L1837P | 1837 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| MYO7A R212C | 212 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R212H | 212 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R241H | 241 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R241C | 241 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R244C | 244 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A A397D | 397 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R1240Q | 1240 | MyTH4 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A R1240W | 1240 | MyTH4 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A L1837H | 1837 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| MYO7A R1873W | 1873 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| USH1C R103C | 103 | PDZ 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A G7V | 7 | Pathogenic / likely pathogenic (★★) | |
| MYO7A G163R | 163 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R395H | 395 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A Q462P | 462 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A L1027P | 1027 | MyTH4 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A P1204T | 1204 | MyTH4 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A G1497R | 1497 | FERM 1 | Pathogenic / likely pathogenic (★★) |
| USH2A C717G | 717 | Laminin EGF-like 4 | Pathogenic / likely pathogenic (★★) |
| USH2A C766Y | 766 | Laminin EGF-like 5 | Pathogenic / likely pathogenic (★★) |
| MYO7A G25R | 25 | Pathogenic / likely pathogenic (★★) | |
| MYO7A G214R | 214 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A E450Q | 450 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R1883Q | 1883 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| MYO7A R1883W | 1883 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| MYO7A P1887L | 1887 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| USH1C R103H | 103 | PDZ 1 | Pathogenic / likely pathogenic (★★) |
| USH1C G104D | 104 | PDZ 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A A26E | 26 | Pathogenic / likely pathogenic (★★) | |
| MYO7A A457V | 457 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R853C | 853 | IQ 5 | Pathogenic / likely pathogenic (★★) |
| MYO7A P1243L | 1243 | MyTH4 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A G1298R | 1298 | FERM 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A Y2015H | 2015 | FERM 2 | Pathogenic / likely pathogenic (★★) |
| MYO7A R2024P | 2024 | FERM 2 | Pathogenic / likely pathogenic (★★) |
| PCDH15 V528D | 528 | Cadherin 5 | Pathogenic / likely pathogenic (★★) |
| USH2A G257R | 257 | Pathogenic / likely pathogenic (★★) | |
| USH2A C536S | 536 | Laminin EGF-like 1 | Pathogenic / likely pathogenic (★★) |
| USH2A P2329H | 2329 | Fibronectin type-III 9 | Pathogenic / likely pathogenic (★★) |
| USH2A Y3143C | 3143 | Fibronectin type-III 18 | Pathogenic / likely pathogenic (★★) |
| MYO7A R83S | 83 | Myosin motor | Pathogenic / likely pathogenic (★★) |
Showing 60 of 128.
Uncertain variants prioritized for review in Usher syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| MYO7A R1168W | 1168 | MyTH4 1 | Conflicting reports (★) | +6: R1168Q at the same position is pathogenic; REVEL 0.948 |
| MYO7A A2009D | 2009 | FERM 2 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A2009T at the same position is pathogenic; REVEL 0.850 |
| MYO7A R666Q | 666 | Myosin motor | Uncertain (★★★) | +6: 3 other pathogenic changes within 3 positions; R666P at the same position is pathogenic; REVEL 0.841 |
Which prediction tools work for Usher syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 94 out of 100
- CATVariant: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 90 out of 100
- MetaSVM: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 89 out of 100
- ESM1b (LLR): 88 out of 100
- MutPred: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 77 out of 100
- SpliceAI: 59 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to MYO7A variants; they fall partly in the same places as the Usher syndrome variants (26 pathogenic / likely pathogenic).
- Rare genetic deafness also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Usher syndrome variants (23 pathogenic / likely pathogenic).
- Autosomal dominant nonsyndromic hearing loss also has ClinVar records linked to MYO7A variants; they fall partly in the same places as the Usher syndrome variants (13 pathogenic / likely pathogenic).
- Hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Usher syndrome variants (4 pathogenic / likely pathogenic).
- Nonsyndromic genetic hearing loss also has ClinVar records linked to MYO7A variants; they fall in the same places as the Usher syndrome variants (4 pathogenic / likely pathogenic).
- Retinitis pigmentosa also has ClinVar records linked to USH2A variants; they fall mostly in different places as the Usher syndrome variants (23 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to PCDH15 variants; they fall mostly in different places as the Usher syndrome variants (6 pathogenic / likely pathogenic).
Diseases related to Usher syndrome
- Autosomal recessive nonsyndromic hearing loss, also linked to MYO7A, PCDH15 and USH1C
- Rare genetic deafness, also linked to MYO7A, PCDH15 and USH2A
- Hearing loss, also linked to MYO7A, PCDH15 and USH1C
- Deafness, also linked to MYO7A, PCDH15 and USH1C
- Retinitis pigmentosa, also linked to MYO7A and USH2A
- Ear malformation, also linked to MYO7A and USH2A
- Autosomal dominant nonsyndromic hearing loss, also linked to MYO7A
- Cone-rod dystrophy, also linked to USH2A
- Nonsyndromic genetic hearing loss, also linked to MYO7A
- Monogenic hearing loss, also linked to MYO7A
- Auditory neuropathy, also linked to MYO7A
- Retinal disorder, also linked to USH2A
Frequently asked questions
Which genes have records linked to Usher syndrome?
This view contains 4 analyzed proteins: MYO7A, USH2A, PCDH15, USH1C. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 128 pathogenic or likely pathogenic variants, 543 variants of uncertain significance and 113 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,000 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center